Education
About Us
Working with TipRanks
Follow Us
Xtant Medical Holdings (XTNT)
:XTNT
Earnings Data
Report Date
Jul 31, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
-0.01Last Year’s EPS
-0.03Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 12, 2025
|% Change Since: 26.92%
|Next Earnings Date:Jul 31, 2025
Earnings Call Sentiment|Positive
Xtant Medical showed strong revenue growth and improved financial performance, highlighted by significant revenue growth and increased guidance. The completion of vertical integration and the launch of new products also signal strategic advancements. However, the decline in spinal implant sales and gross margin pressure, along with uncertainties related to CMS policy changes, pose challenges. Overall, the highlights outweigh the lowlights, indicating a positive outlook.Company Guidance
During the call, Xtant Medical provided guidance indicating an anticipated total revenue for fiscal year 2025 in the range of $127 million to $131 million, representing an 8% to 11% growth. The company expects mid-double-digit revenue growth in its biologics product family, while hardware revenue is expected to remain flat or modestly down year-over-year. Xtant achieved a first-quarter revenue of $32.9 million, marking an 18% increase from the same period in 2024, and a positive net income of $58,000, compared to a net loss of $4.4 million in the prior year. Gross margin for the first quarter was 61.5%, slightly down from 62.1% the previous year, due to inventory disposal charges, but this was partially offset by improved product costs following vertical integration. The company successfully reduced its operating expenses, down to $19.2 million from $20.8 million in the previous year. Additionally, adjusted EBITDA for the first quarter of 2025 was $3 million, compared to a loss of $1 million in the same period of 2024. Xtant also noted that they do not anticipate the need to raise additional capital, supported by recent cost savings and strategic investments.Strong Revenue Growth
Xtant Medical reported a revenue growth of 18% year-over-year, reaching $32.9 million in total revenue for Q1 2025.
Improved Financial Performance
The company achieved positive net income of $58,000, compared to a net loss of $4.4 million in the same period last year, and adjusted EBITDA of $3 million, a significant improvement from a $1 million loss in Q1 2024.
Termination of Restrictive Agreement
Xtant terminated a restrictive investor rights agreement with OrbiMed, marking a new chapter for the company and allowing more flexibility in operations.
Vertical Integration Completed
The company completed full vertical integration of its previously outsourced biologics products, now manufacturing all major biologics product categories in-house.
Launch of New Products
Xtant launched two new innovative products, Trivium and FibreX, to rejuvenate its core demineralized bone offerings.
Increased Revenue Guidance
The company increased its full-year 2025 revenue guidance to $127 million to $131 million, representing an 8% to 11% growth.
---
XTNT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
XTNT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 12, 2025 | $0.52 | $0.60 | +15.38% |
Mar 06, 2025 | $0.48 | $0.46 | -4.17% |
Nov 12, 2024 | $0.54 | $0.47 | -12.96% |
Aug 08, 2024 | $0.65 | $0.65 | 0.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Xtant Medical Holdings (XTNT) report earnings?
Xtant Medical Holdings (XTNT) is schdueled to report earning on Jul 31, 2025, TBA Not Confirmed.
What is Xtant Medical Holdings (XTNT) earnings time?
Xtant Medical Holdings (XTNT) earnings time is at Jul 31, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is XTNT EPS forecast?
XTNT EPS forecast for the fiscal quarter 2025 (Q2) is -0.01.
---